Allarity Therapeutics Financial Overview
Allarity Therapeutics's market cap is currently $16.91M. The company's EPS TTM is $-0.19; its P/E ratio is -0.67; Allarity Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
